Glaukos GKOS US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Glaukos in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Glaukos's us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Glaukos's US — revenue?
- Glaukos (GKOS) reported US — revenue of $112.34M in Q1 2026.
- How has Glaukos's US — revenue changed year-over-year?
- Glaukos's US — revenue increased by 49.7% year-over-year, from $75.07M to $112.34M.
- What is the long-term trend for Glaukos's US — revenue?
- Over 4 years (2021 to 2025), Glaukos's US — revenue has grown at a 13.8% compound annual growth rate (CAGR), from $223.79M to $375.04M.
- What does US — revenue mean?
- The total sales revenue generated from customers located in the United States.
- How do you interpret US — revenue?
- An increase indicates successful product adoption, effective sales execution, or expansion of the installed base, while a decrease may signal competitive pressure or market saturation.
- How does US — revenue compare across companies?
- Comparable to regional net sales reported by other medical device manufacturers, typically benchmarked against regional market growth rates.